Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis. [electronic resource]
Producer: 20120815Description: 5397-404 p. digitalISSN:- 1528-0020
- Aged
- Aged, 80 and over
- Amyloidosis -- drug therapy
- Antineoplastic Agents -- adverse effects
- Dexamethasone -- adverse effects
- Disease-Free Survival
- Drug Therapy, Combination -- adverse effects
- Female
- Hematologic Tests
- Humans
- Immunoglobulin Light Chains -- metabolism
- Male
- Middle Aged
- Plasma Cells -- drug effects
- Thalidomide -- adverse effects
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.